Sunday, August 8, 2021

Thyroid-Stimulating Hormone Receptor Antibodies in Refractory Graves’ Disease Change Differently According to the Type of Definitive Therapy Administered

xlomafota13 shared this article with you from Inoreader

showCoverImage?journalCode=

Clinical Thyroidology, Volume 33, Issue 8, Page 350-353, August 2021.
View on the web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...